India's Pharma Vision: 100 New Drugs by 2047

Pankaj R Patel, Chairman of Zydus Lifesciences, envisions India delivering 100 new drugs by 2047, highlighting the importance of research, innovation, and capable human resources. He addressed myths about drug discovery costs and praised India's leadership. Ajay Piramal also remarked positively on India's current trajectory and global standing.

The Indian pharmaceutical industry is set to introduce 100 new drugs to global markets by 2047, according to Pankaj R Patel, Chairman of Zydus Lifesciences. Speaking at an event, he emphasized the critical roles of research, innovation, and a focus on the social good.

Patel debunked the myth that drug discovery requires billions, asserting that with the right strategies and capable workforce, it is achievable. He highlighted the necessity for a work environment that fosters passion among employees and emphasized evolving leadership paradigms focused on humility and global insight.

Echoing Patel, Ajay Piramal, Chairman of Piramal Group, added that India is strategically well-placed economically and leadership-wise, marking it as an opportune time for growth. He expressed optimism about India's trajectory and its increasing global prominence.